Zhong Yuan Bio-Technology Holdings Limited

FRC's fair value estimate for Zhong Yuan Bio-Technology Holdings Limited, and the rating behind it. ZHYBF last traded at $2.02, 118.8× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Zhong Yuan Bio-Technology Holdings Limited. Starting points for Zhong Yuan Bio-Technology Holdings Limited: P/E 118.8, EPS $0.02, beta 4.64 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Zhong Yuan Bio-Technology Holdings Limited. Zhong Yuan Bio-Technology Holdings Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Zhong Yuan Bio-Technology Holdings Limited. Trailing twelve-month EPS for Zhong Yuan Bio-Technology Holdings Limited stands at $0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Zhong Yuan Bio-Technology Holdings Limited. Zhong Yuan Bio-Technology Holdings Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Zhong Yuan Bio-Technology Holdings Limited valued side by side against its closest peers. Zhong Yuan Bio-Technology Holdings Limited is measured against Medical - Distribution peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Zhong Yuan Bio-Technology Holdings Limited, and how their positions are changing. At a $35.8M market value, institutional positions materially move Zhong Yuan Bio-Technology Holdings Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Zhong Yuan Bio-Technology Holdings Limited executives and directors. Shares of Zhong Yuan Bio-Technology Holdings Limited have traded between $2.00 and $2.02 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Zhong Yuan Bio-Technology Holdings Limited. Zhong Yuan Bio-Technology Holdings Limited is a $35.8M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Zhong Yuan Bio-Technology Holdings Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Zhong Yuan Bio-Technology Holdings Limited. Coverage tracks Zhong Yuan Bio-Technology Holdings Limited within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.